Condition: Amyloid Plaque · Beta-Amyloid · DSAD · Sponsor: AC Immune SA
The purpose of this study is to assess the safety, tolerability, immunogenicity and pharmacodynamic effects of ACI-24.060 in subjects with prodromal Alzheimer's disease and in non-demented adults with Down syndrome.
This description comes directly from the study's public registry record.
Olivier Sol, MD · +41 21 345 9121 · clinicaltrials@acimmune.com
Benedicte Le · +41 21 345 9121 · clinicaltrials@acimmune.com
Always discuss trial participation with your own doctor first.
| Barrow Neurological Institute | Phoenix, Arizona, United States | Withdrawn |
| K2 Medical Research The Villages LLC | Lady Lake, Florida, United States | Recruiting |
| Charter Research, LLC | Orlando, Florida, United States | Recruiting |
| Headlands Horizons LLC | Orlando, Florida, United States | Not Yet Recruiting |
| Charter Research, LLC | The Villages, Florida, United States | Recruiting |
| Indiana University / IU Health | Indianapolis, Indiana, United States | Active Not Recruiting |
| University of Kansas Medical Center Research Institute | Fairway, Kansas, United States | Active Not Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Active Not Recruiting |
| The Washington University | St Louis, Missouri, United States | Active Not Recruiting |
| Flourish Research | Matthews, North Carolina, United States | Not Yet Recruiting |
| Neurology Clinical, P.C. | Cordova, Tennessee, United States | Recruiting |
| Vanderbilt University Medical Center | Nashville, Tennessee, United States | Active Not Recruiting |
+ 14 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05462106